<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Porter Fry | Activity</title>
	<link>https://www.catswannabecats.com/members/spygun79/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/spygun79/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Porter Fry.</description>
	<lastBuildDate>Fri, 19 Jun 2026 15:42:02 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">a0afc99ff28983fae7b61cb32ac33505</guid>
				<title>Porter Fry posted an update: Background MicroRNAs (miRNAs) are a class of small [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/26028/</link>
				<pubDate>Mon, 09 Jun 2025 13:10:42 -0400</pubDate>

									<content:encoded><![CDATA[<p>Background MicroRNAs (miRNAs) are a class of small non-coding RNAs, which participate in the regulation of cell differentiation. Previous studies have demonstrated that miR-9-5p plays a key role in cancer cell development, but the mechanisms by which miR-9-5p regulates adipogenesis remain poorly understood. The present study intended to&hellip;<span class="activity-read-more" id="activity-read-more-26028"><a href="https://www.catswannabecats.com/activity/p/26028/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7733b10be37d51d40f4171f1249be0ad</guid>
				<title>Porter Fry posted an update: s for patients, a lack of equity, and a poor organizational [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/24766/</link>
				<pubDate>Sun, 08 Jun 2025 13:32:57 -0400</pubDate>

									<content:encoded><![CDATA[<p>s for patients, a lack of equity, and a poor organizational culture. In addition, the study identified a lack of means of communicating urgent imaging findings and a lack of promptness and timeliness to care from the consultant radiologists. Conclusion The low level of care of medical imaging services observed in Ghana is reflected in the large&hellip;<span class="activity-read-more" id="activity-read-more-24766"><a href="https://www.catswannabecats.com/activity/p/24766/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4d474fa16cc74431aa7e16e0010ae901</guid>
				<title>Porter Fry posted an update: Furthermore, DS-5272 significantly decreased vascular [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/21565/</link>
				<pubDate>Fri, 06 Jun 2025 14:08:15 -0400</pubDate>

									<content:encoded><![CDATA[<p>Furthermore, DS-5272 significantly decreased vascular endothelial growth factor concentrations in both sera and ascites. Combined therapy with MDM2 inhibitors and everolimus showed synergistic, and dose-reduction potential, for clear cell carcinoma treatment. Our findings suggest that MDM2 inhibitors represent promising molecular targeted therapy&hellip;<span class="activity-read-more" id="activity-read-more-21565"><a href="https://www.catswannabecats.com/activity/p/21565/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4c55d40ac2e28df3eb31e9013a21e990</guid>
				<title>Porter Fry posted an update: The results of the CCD pilot project to study the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19218/</link>
				<pubDate>Wed, 04 Jun 2025 13:07:35 -0400</pubDate>

									<content:encoded><![CDATA[<p>The results of the CCD pilot project to study the antiplatelet profile of dipyridamole in patients with such a cause of ischemic NMC as Ph-negative myeloproliferative diseases are discussed separately. It is noted that when prescribing both dipyridamole and acetylsalicylic acid preparations, comparable platelet aggregation levels are determined.&hellip;<span class="activity-read-more" id="activity-read-more-19218"><a href="https://www.catswannabecats.com/activity/p/19218/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3de16b000c48831b39e3c25386b59f25</guid>
				<title>Porter Fry posted an update: ALP-activated DCs showed an ample capacity to differentiate [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18159/</link>
				<pubDate>Tue, 03 Jun 2025 12:53:23 -0400</pubDate>

									<content:encoded><![CDATA[<p>ALP-activated DCs showed an ample capacity to differentiate naive T cells to Th1 and activated CD8+ T cells effectively. The systemic administration of DCs that pulse ALP and ovalbumin peptides strongly increased cytotoxic T lymphocyte (CTL) activity (by 9.5% compared to that in the control vaccine groups), the generation of CD107a-producing&hellip;<span class="activity-read-more" id="activity-read-more-18159"><a href="https://www.catswannabecats.com/activity/p/18159/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5d875ea2b7643dfc7b7be8b0779b5098</guid>
				<title>Porter Fry posted an update: Furthermore, Rho GTPases play a crucial role in the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/7669/</link>
				<pubDate>Sat, 31 May 2025 19:45:21 -0400</pubDate>

									<content:encoded><![CDATA[<p>Furthermore, Rho GTPases play a crucial role in the development of radio- and chemoresistance e.g. under cisplatin-based cancer treatment. This article provides an in-depth overview on the role of Rho GTPases in gynecological cancers, highlights relevant signaling pathways and pathomechanisms, and sheds light on their involvement in tumor&hellip;<span class="activity-read-more" id="activity-read-more-7669"><a href="https://www.catswannabecats.com/activity/p/7669/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7b7c3d5092eaf704b124f626b6a75b5c</guid>
				<title>Porter Fry became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/7579/</link>
				<pubDate>Sat, 31 May 2025 19:35:42 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>